BioRestorative Therapies
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. BioRestorative Therapies's past years’ income statements indicate that its last revenue has increased compared to the previous period by 22% to $145,800. The net income raised on -$10,417,704 and profit margin reached -7145%. Total operating expenses were $15,366,574.
Profit Margin
| 2014 | 415.99K | -5.58M | -1343.19% |
|---|---|---|---|
| 2015 | 628.91K | -7.92M | -1259.87% |
| 2016 | 36.35K | -8.63M | -23755.44% |
| 2017 | 81K | -9.44M | -11660.07% |
| 2018 | 111K | -12.51M | -11277.3% |
| 2019 | 130K | -17.92M | -13785.47% |
| 2020 | 77K | -12.25M | -15915.17% |
| 2021 | 46K | -29.93M | -65083.92% |
| 2022 | 119.8K | -18.01M | -15037.99% |
| 2023 | 145.8K | -10.41M | -7145.2% |
BRTX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 145.8K | 119.8K | 46K | 77K | 130K | 111K | 81K | 36.35K | 628.91K | 415.99K |
Cost of revenue | 0 | 280.66K | 205.20K | 0 | 0 | 0 | 259.26K | 102 | 261.50K | 213.83K |
Gross profit | 145.8K | -160.86K | -159.20K | 77K | 130K | 111K | -178.26K | 36.25K | 367.41K | 202.16K |
Operating exp. | ||||||||||
Research and development | 4.03M | 3.51M | 729.05K | 876.82K | 1.72M | 1.51M | 2.15M | 2.88M | 2.10M | 1.43M |
Selling and marketing | 168.02K | 0 | 12.29K | 28.28K | 321.28K | 352.20K | 65.45K | 86.45K | 168.35K | 125.62K |
Total operating expenses | 15.36M | 18.98M | 26.35M | 2.82M | 8.56M | 7.75M | 8.45M | 7.83M | 7.53M | 5.12M |
Operating income | -15.22M | -18.97M | -26.30M | -2.75M | -8.43M | -7.64M | -8.37M | -7.79M | -7.17M | -4.92M |
Other income (expenses), net | 4.80M | 479.25K | -17.99M | -8.52M | -6.21M | -1.64M | -1.07M | -75.09K | -753.11K | -665.10K |
Income before tax | -10.41M | -18.49M | -44.30M | -11.27M | -14.64M | -12.51M | -9.44M | -8.63M | -7.92M | -5.58M |
Income tax expense | 0 | -479.25K | -14.36M | 981.99K | 3.27M | -1.64M | 1.02M | 717.33K | 263.58K | 285.27K |
Net income | -10.41M | -18.01M | -29.93M | -12.25M | -17.92M | -12.51M | -9.44M | -8.63M | -7.92M | -5.58M |
Earnings per share | ||||||||||
Basic EPS | -2.47 | -4.98 | -25.21 | -31.05 | -3.21K | -4.26K | -6.18K | -7.35K | -9.58K | -13.17K |
Diluted EPS | -2.47 | -4.98 | -25.21 | -31.05 | -3.21K | -4.26K | -6.18K | -7.35K | -9.58K | -13.17K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |